share_log

JMP Securities Initiates Coverage On Werewolf Therapeutics With Market Outperform Rating, Announces Price Target of $12

Moomoo 24/7 ·  Apr 3 04:47

JMP Securities analyst Reni Benjamin initiates coverage on Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform rating and announces Price Target of $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment